What is the price target for CGEN stock?
11 analysts have analysed CGEN and the average price target is 6.38 USD. This implies a price increase of 184.6% is expected in the next year compared to the current price of 2.24.
COMPUGEN LTD (CGEN) Forecast, Price Target & Analyst Ratings
NASDAQ:CGEN • IL0010852080
Current stock price
2.24 USD
+0.03 (+1.36%)
At close:
2.28 USD
+0.04 (+1.79%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COMPUGEN LTD (CGEN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 18, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.07
- Revenue Estimate
- 2.492M
Price Target Details & History
Consensus Price Target and Range
Mean target
$6.38
Upside
+ 184.60%
From current price of $2.24 to mean target of $6.38, Based on 11 analyst forecasts
Low
$4.04
Median
$4.08
High
$13.65
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for CGEN. The average price target is 6.38 USD. This implies a price increase of 184.6% is expected in the next year compared to the current price of 2.24.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
87.27%
CGEN was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CGEN.
In the previous month the buy percentage consensus was at a similar level.
CGEN was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-07 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-21 | Truist Securities | Maintains | Buy -> Buy |
| 2024-03-08 | Truist Securities | Maintains | Buy -> Buy |
| 2023-12-19 | Stifel | Maintains | Buy -> Buy |
| 2023-08-23 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-07 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-06 | EF Hutton | Reiterate | Buy |
| 2023-05-26 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-24 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-02-28 | Oppenheimer | Reiterate | Outperform |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-11-15 | Oppenheimer | Maintains | Outperform |
| 2022-08-23 | Truist Securities | Maintains | Buy |
| 2022-08-08 | JMP Securities | Maintains | Market Outperform |
| 2022-08-08 | Oppenheimer | Maintains | Outperform |
| 2022-08-05 | Jefferies | Downgrade | Buy -> Hold |
| 2022-02-25 | Oppenheimer | Maintains | Outperform |
| 2022-02-25 | SVB Leerink | Maintains | Outperform |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 18, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.07
- Revenue Estimate
- 2.492M
- Revenue Q2Q
- 9.11%
- EPS Q2Q
- 6.50%
- Number of Analysts
- 6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
CGEN is expected to report earnings on 5/18/2026. The consensus EPS estimate for the next earnings is -0.07 USD and the consensus revenue estimate is 2.49M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.5M 25.00% | 33.459M 346.12% | 27.864M -16.72% | 6.902M -75.23% | 18.285M 164.92% | 28.995M 58.57% | 34.714M 19.72% | 31.266M -9.93% | 52.852M 69.04% | 98.961M 87.24% | 82.853M -16.28% | 99.141M 19.66% | |
| EBITDA YoY % growth | -34.89M -0.81% | -12.516M 64.13% | -14.405M -15.09% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -35.37M -0.86% | -12.992M 63.27% | -14.891M -14.62% | -20.182M -35.53% | -23.501M -16.45% | -25.376M -7.98% | -25.563M -0.74% | -38.72M -51.47% | -11.188M 71.11% | 18.029M 261.15% | 32.748M 81.64% | 77.609M 136.99% | |
| Operating Margin | -471.60% | -38.83% | -53.44% | -292.40% | -128.53% | -87.52% | -73.64% | -123.84% | -21.17% | 18.22% | 39.53% | 78.28% | |
| EPS YoY % growth | -0.40 | -0.22 45.00% | -0.16 27.27% | -0.18 331.25% | -0.22 -158.99% | -0.17 23.36% | -0.40 -137.80% | -0.37 5.97% | -0.03 91.82% | 0.03 200.00% | 0.39 1,166.67% | 0.71 84.21% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 6.50% | -0.08 -2.00% | -0.08 -21.42% | -0.08 -113.60% |
| Revenue Q2Q % growth | 2.492M 9.11% | 1.275M 1.43% | 1.275M -32.58% | 1.275M -98.11% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.568M 9.85% | -8.211M 2.59% | -8.313M -5.32% | -8.313M -264.88% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-45.42%
EPS Next 5 Year
-15.80%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
71.33%
Revenue Next 5 Year
50.25%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
COMPUGEN LTD / CGEN Forecast FAQ
What is the next earnings date for CGEN stock?
COMPUGEN LTD (CGEN) will report earnings on 2026-05-18.
What are the consensus estimates for CGEN stock next earnings?
The consensus EPS estimate for the next earnings of COMPUGEN LTD (CGEN) is -0.07 USD and the consensus revenue estimate is 2.49M USD.
How many analysts have analysed COMPUGEN LTD (CGEN)?
The number of analysts covering COMPUGEN LTD (CGEN) is 11.